Ermont, France

Ali Ladram

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ali Ladram

Introduction

Ali Ladram is a notable inventor based in Ermont, France. He has made significant contributions to the field of antimicrobial peptides, with a focus on their applications in pharmaceuticals and agriculture. His work has led to the development of novel compounds that have the potential to revolutionize the way we approach antimicrobial treatments.

Latest Patents

Ali Ladram holds 2 patents related to his research on antimicrobial peptides. His latest patents include "Analogues of temporin-SHa and uses thereof." This invention pertains to novel antimicrobial peptides and pharmaceutical compositions that incorporate these peptides. The applications of these inventions extend to antimicrobial drugs, disinfectants, pesticides, and preservatives. Additionally, the patents discuss the development of transgenic plants that express these innovative peptides, showcasing the potential for agricultural applications.

Career Highlights

Throughout his career, Ali Ladram has worked with prestigious institutions, including Université Pierre et Marie Curie (Paris 6) and Institut de Recherche pour le Développement. His research has garnered attention for its practical applications in combating microbial resistance and enhancing agricultural productivity.

Collaborations

Ali has collaborated with esteemed colleagues such as Denis Sereno and Bruno Oury. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Ali Ladram's innovative work in the field of antimicrobial peptides highlights his commitment to addressing critical challenges in health and agriculture. His patents represent a significant step forward in the development of effective antimicrobial solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…